Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
290.8 GBX | +1.31% | +33.76% | +30.72% |
29/04 | FTSE 100 as investors look to Fed rate decision | AN |
29/04 | Transcript : Oxford Biomedica plc, Q4 2023 Earnings Call, Apr 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.72% | 358M | |
-1.17% | 104B | |
+2.87% | 97.47B | |
+4.40% | 22.25B | |
-14.77% | 21.68B | |
-8.65% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |
- Stock Market
- Equities
- OXB Stock
- News Oxford Biomedica plc
- Oxford Biomedica, Novartis Extend Commercial Supply Agreement For Lentiviral Vectors Until 2028